Detalles de la búsqueda
1.
CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy.
Immunity
; 57(3): 541-558.e7, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38442708
2.
A Vulnerability of a Subset of Colon Cancers with Potential Clinical Utility.
Cell
; 165(2): 317-30, 2016 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27058664
3.
Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells.
Nature
; 611(7936): 603-613, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36352230
4.
Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE.
Br J Surg
; 110(9): 1161-1170, 2023 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37442562
5.
The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE.
HPB (Oxford)
; 25(9): 985-999, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37471055
6.
Linked Colour imaging for the detection of polyps in patients with Lynch syndrome: a multicentre, parallel randomised controlled trial.
Gut
; 71(3): 553-560, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34086597
7.
Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer.
Gut
; 71(12): 2502-2517, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35477539
8.
Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets.
Clin Chem
; 68(9): 1164-1176, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35769009
9.
Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy.
Genes Immun
; 22(2): 108-119, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34079092
10.
Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis.
Gut
; 68(4): 684-692, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29666172
11.
Impact of endoscopy system, high definition, and virtual chromoendoscopy in daily routine colonoscopy: a randomized trial.
Endoscopy
; 51(3): 237-243, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30646403
12.
Zic2 mutation causes holoprosencephaly via disruption of NODAL signalling.
Hum Mol Genet
; 25(18): 3946-3959, 2016 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27466203
13.
Comprehensive pharmacogenetic profiling of the epidermal growth factor receptor pathway for biomarkers of response to, and toxicity from, cetuximab.
J Med Genet
; 54(8): 567-571, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28283541
14.
Deregulation of ZIC Family Members in Oncogenesis.
Adv Exp Med Biol
; 1046: 329-338, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29442329
15.
Publisher Correction: Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy.
Genes Immun
; 23(8): 260, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36456662
16.
Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching.
Br J Cancer
; 116(1): 58-65, 2017 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27884016
17.
Virtual chromoendoscopy (I-SCAN) detects more polyps in patients with Lynch syndrome: a randomized controlled crossover trial.
Endoscopy
; 49(4): 342-350, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28107763
18.
Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and Patients.
Oncologist
; 21(3): 292-300, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26888693
19.
Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
Gastroenterology
; 148(1): 88-99, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25305506
20.
ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours.
BMC Cancer
; 16: 339, 2016 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-27246726